Price Alert: Shares of MediWound (MDWD) Trade 6.32% Higher at Midday June 21

Equities Staff  |

MediWound Ltd (NASDAQ: MDWD) shares moved 6.32%, or $0.086 per share, as on 11:34:41 est today. Since opening the day at $1.25, 76,680 shares of MediWound have exchanged hands and the stock has ranged between $1.48 and $1.31.  

So far this year the company is down 42.37%.

MediWound anticipates its next earnings on 2022-08-10.

For technical charts, analysis, and more on MediWound visit the company profile.

About MediWound Ltd

MediWound is a biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Its strategy is centered around its validated enzymatic platform technology, focused on next-generation bio-active therapies for burn and wound care and biological medicinal products for tissue repair.

To get more information on MediWound Ltd and to follow the company's latest updates, you can visit the company's profile page here: MediWound Ltd's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Will Mining Stocks Fall Further?
3 Reasons To Be Optimistic About the Global Shipping Industry
The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks

Market Movers

Sponsored Financial Content